95 related articles for article (PubMed ID: 2903020)
1. Enantioselective disposition and protein binding of [(5,6-dichloro-9a-propyl-3-oxo-2,3,9,9a-tetrahydro-1-H-fluoren-7 -yl)-oxy] acetic acid, a new cerebral antiedemic agent, in rats.
Lin JH; Hsieh JY
Drug Metab Dispos; 1988; 16(4):540-5. PubMed ID: 2903020
[TBL] [Abstract][Full Text] [Related]
2. Agents for the treatment of brain edema. 2. [(2,3,9,9a-Tetrahydro-3-oxo-9a-substituted-1H-fluoren-7-yl)oxy]+ ++alkanoi c acids and some of their analogues.
Cragoe EJ; Woltersdorf OW; Gould NP; Pietruszkiewicz AM; Ziegler C; Sakurai Y; Stokker GE; Anderson PS; Bourke RS; Kimelberg HK
J Med Chem; 1986 May; 29(5):825-41. PubMed ID: 3701792
[TBL] [Abstract][Full Text] [Related]
3. Insight into stereoselective disposition of enantiomers of a potent antithrombotic agent, S002-333 following administration of the racemic compound to mice.
Bhateria M; Rachumallu R; Yerrabelli S; Saxena AK; Bhatta RS
Eur J Pharm Sci; 2017 Apr; 101():107-114. PubMed ID: 28189817
[TBL] [Abstract][Full Text] [Related]
4. Cytoxicity of [(5,6-dichloro-9a-n-propyl-2,3,9,9a-tetrahydro-3-oxo-1H fluoren-7-yl)oxy]acetic acid, an agent known to reduce brain edema.
Hall IH; Wyrick SD
Biomed Pharmacother; 1996; 50(1):19-23. PubMed ID: 8672727
[TBL] [Abstract][Full Text] [Related]
5. Interspecies differences in stereoselective protein binding and clearance of MK-571.
Tocco DJ; deLuna FA; Duncan AE; Hsieh JH; Lin JH
Drug Metab Dispos; 1990; 18(4):388-92. PubMed ID: 1976057
[TBL] [Abstract][Full Text] [Related]
6. Enantioselective kinetics of verapamil and norverapamil in isolated perfused rat livers.
Mehvar R; Reynolds JM; Robinson MA; Longstreth JA
Pharm Res; 1994 Dec; 11(12):1815-9. PubMed ID: 7899248
[TBL] [Abstract][Full Text] [Related]
7. Stereoselective disposition of S-8666, a novel uricosuric antihypertensive diuretic, and its N-monodemethylated metabolite in a perfused rat liver preparation. Effect of protein binding on the kinetics of S-8666.
Higaki K; Nakano M
Drug Metab Dispos; 1992; 20(3):350-5. PubMed ID: 1355707
[TBL] [Abstract][Full Text] [Related]
8. Dose-dependent stereopharmacokinetics of 5,6-dihydro-4H-4(isobutylamino)thieno(2,3-B)thiopyran-2-sulfonamide-7,7 -dioxide , a potent carbonic anhydrase inhibitor, in rats.
Lin JH; Ulm EH; Los LE
Drug Metab Dispos; 1991; 19(1):233-8. PubMed ID: 1673405
[TBL] [Abstract][Full Text] [Related]
9. Stereoselective pharmacokinetics of ketoprofen in the rat. Influence of route of administration.
Foster RT; Jamali F
Drug Metab Dispos; 1988; 16(4):623-6. PubMed ID: 2903033
[TBL] [Abstract][Full Text] [Related]
10. Stereoselective aspects in the pharmacokinetics and pharmacodynamics of acenocoumarol and its amino and acetamido derivatives in the rat.
Thijssen HH; Baars LG; Drittij-Reijnders MJ
Drug Metab Dispos; 1985; 13(5):593-7. PubMed ID: 2865109
[TBL] [Abstract][Full Text] [Related]
11. Chiral pharmacokinetics and inversion of enantiomers of a new quinoxaline topoisomerase IIbeta poison in the rat.
Zheng H; Jiang C; Chiu MH; Covey JM; Chan KK
Drug Metab Dispos; 2002 Mar; 30(3):344-8. PubMed ID: 11854156
[TBL] [Abstract][Full Text] [Related]
12. Differences in the stereoselective pharmacokinetics of pazinaclone (DN-2327), a new anxiolytic, and its active metabolite after intravenous and oral single doses to dogs.
Hussein Z; Mulford DJ; Bopp BA; Granneman GR
Drug Metab Dispos; 1993; 21(5):805-10. PubMed ID: 7902240
[TBL] [Abstract][Full Text] [Related]
13. Species-dependent stereopharmacokinetics of MK-927, a potent carbonic anhydrase inhibitor.
Lin JH; Chen IW; Lin TH
Drug Metab Dispos; 1991; 19(4):816-22. PubMed ID: 1680660
[TBL] [Abstract][Full Text] [Related]
14. Stereoselective plasma protein binding and target tissue distribution of clausenamide enantiomers in rats.
Zhu CJ; Zhang JT
Chirality; 2009 Mar; 21(3):402-6. PubMed ID: 18655159
[TBL] [Abstract][Full Text] [Related]
15. Stereoselective disposition of propranolol in rabbits. Role of presystemic organs and dose.
Marier JF; Pichette V; du Souich P
Drug Metab Dispos; 1998 Feb; 26(2):164-9. PubMed ID: 9456303
[TBL] [Abstract][Full Text] [Related]
16. Enantioselective pharmacokinetics of etodolac in the rat: tissue distribution, tissue binding, and in vitro metabolism.
Brocks DR; Jamali F
J Pharm Sci; 1991 Nov; 80(11):1058-61. PubMed ID: 1839997
[TBL] [Abstract][Full Text] [Related]
17. Stereoselective pharmacokinetics of a novel uricosuric antihypertensive diuretic in rats: pharmacokinetic interaction between enantiomers.
Higaki K; Kadono K; Nakano M
J Pharm Sci; 1992 Sep; 81(9):935-9. PubMed ID: 1432643
[TBL] [Abstract][Full Text] [Related]
18. Enantioselective disposition of clenbuterol in rats.
Hirosawa I; Ishikawa M; Ogino M; Ito H; Hirao T; Yamada H; Asahi M; Kotaki H; Sai Y; Miyamoto K
Biopharm Drug Dispos; 2014 May; 35(4):207-17. PubMed ID: 24323748
[TBL] [Abstract][Full Text] [Related]
19. Stereoselectivity in the metabolism of disopyramide enantiomers in rat and dog.
Cook CS; Karim A; Sollman P
Drug Metab Dispos; 1982; 10(2):116-21. PubMed ID: 6124395
[TBL] [Abstract][Full Text] [Related]
20. DPOFA, a Cl⁻/HCO₃⁻ exchanger antagonist, stimulates fluid absorption across basolateral surface of the retinal pigment epithelium.
Iserovich P; Qin Q; Petrukhin K
BMC Ophthalmol; 2011 Nov; 11():33. PubMed ID: 22085910
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
